Furthermore, the utility of ANGPTL2 as a predictive biomarker for thyroid cancer was evaluated by receiver operating characteristic (ROC) analysis with the data from TCGA (Fig. 6a, b). The gene discussed is ANGPTL2; the disease is thyroid gland carcinoma.